Extracellular Vesicles Released from Cancer Cells Promote Tumorigenesis by Inducing Epithelial to Mesenchymal Transition via β-Catenin Signaling
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24043500 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Vamshikrishna Malyla und 5 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia. Hauptthemen laut MEDLINE: Extracellular Vesicles, Lung Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rebecca L. Cooper Medical Research Foundation, International Association for the Study of Lung Cancer Foundation, USA, Cancer Council New South Wales.
Abstract (Originalsprache)
Lung cancer is the leading cause of cancer-related deaths globally, in part due to a lack of early diagnostic tools and effective pharmacological interventions. Extracellular vesicles (EVs) are lipid-based membrane-bound particles released from all living cells in both physiological and pathological states. To understand the effects of lung-cancer-derived EVs on healthy cells, we isolated and characterized EVs derived from A549 lung adenocarcinoma cells and transferred them to healthy human bronchial epithelial cells (16HBe14o). We found that A549-derived EVs carry oncogenic proteins involved in the pathway of epithelial to mesenchymal transition (EMT) that are regulated by β-catenin. The exposure of 16HBe14o cells to A549-derived EVs resulted in a significant increase in cell proliferation, migration, and invasion via upregulating EMT markers such as E-Cadherin, Snail, and Vimentin and cell adhesion molecules such as CEACAM-5, ICAM-1, and VCAM-1, with concomitant downregulation of EpCAM. Our study suggests a role for cancer-cell-derived EVs to induce tumorigenesis in adjacent healthy cells by promoting EMT via β-catenin signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia.
- Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW 2007, Australia.
- Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, NSW 2007, Australia.
ORCID-Profile: Keshav Raj Paudel, Gabriele De Rubis, Philip M Hansbro, Kamal Dua
Förderung
- Rebecca L. Cooper Medical Research Foundation
- International Association for the Study of Lung Cancer Foundation, USA
- Cancer Council New South Wales
- Cancer Council NSW
- National Health and Medical Research Council
- University of Technology Sydney, Australia
- Rebecca L Cooper Medical Research Foundation
- Maridulu Budyari Gumal—Sydney Partnership for Health Education, Research and Enterprise (SPHERE)
Zitieren
APA
Malyla, V., Paudel, K. R., Rubis, G., Hansbro, N. G., Hansbro, P. M., & Dua, K. (2023). Extracellular Vesicles Released from Cancer Cells Promote Tumorigenesis by Inducing Epithelial to Mesenchymal Transition via β-Catenin Signaling. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043500
Vancouver
Malyla V, Paudel KR, Rubis G, Hansbro NG, Hansbro PM, Dua K. Extracellular Vesicles Released from Cancer Cells Promote Tumorigenesis by Inducing Epithelial to Mesenchymal Transition via β-Catenin Signaling. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043500
BibTeX
@article{Malyla2023,
author = {Malyla, Vamshikrishna and Paudel, Keshav Raj and Rubis, Gabriele De and Hansbro, Nicole G and Hansbro, Philip M and Dua, Kamal},
title = {Extracellular Vesicles Released from Cancer Cells Promote Tumorigenesis by Inducing Epithelial to Mesenchymal Transition via β-Catenin Signaling},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24043500}
}
EUVIMED